Dow Up0.06% Nasdaq Up1.27%

Sagent Pharmaceuticals, Inc. (SGNT)

-NasdaqGS
31.84 Up 0.39(1.24%) 3:11PM EDT - Nasdaq Real Time Price
ProfileGet Profile for:
Sagent Pharmaceuticals, Inc.
1901 North Roselle Road
Suite 700
Schaumburg, IL 60195
United States - Map
Phone: 847-908-1600
Fax: 847-908-1601
Website: http://www.sagentpharma.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Drugs - Generic
Full Time Employees:269

Business Summary 

Sagent Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, sources, manufactures, and markets pharmaceutical products, principally injectable-based generic equivalents to branded products in the United States. The company offers anti-infective products, such as Cefepime, an antibiotic used to treat infections of the urinary tract, and skin and skin structures, as well as moderate to severe pneumonia, intra-abdominal infections, and as empiric therapy for febrile neutropenic patients; and Levofloxacin, a fluoroquinolone antibacterial for the treatment of infections caused by susceptible bacteria, including nosocomial and community acquired pneumonia, sinusitis, chronic bronchitis, skin and skin structure infections, prostatitis, urinary tract infection, and pyelonephritis in adults of age 18 years or older. It also provides oncology products consisting of Docetaxel, an antineoplastic agent used to treat advanced or metastatic breast cancer after chemotherapy failure; Leucovorin Calcium, a folic acid derivative used to prevent harmful effects of methotrexate when methotrexate is used to treat certain types of cancer; and Zoledronic Acid, a bisphosphonate given intravenously to prevent skeletal fractures in patients with cancers such as multiple myeloma and prostate cancer, as well as for treating osteoporosis. In addition, the company offers critical care products comprising Heparin, an anticoagulant used to prevent and treat blood clotting during and after surgery and dialysis. As of December 31, 2013, its product portfolio included 53 marketed products. It sells its products to hospitals, integrated delivery networks, and alternative site facilities through pharmaceutical wholesalers and specialty distributors. The company was formerly known as Sagent Holding Co. and changed its name to Sagent Pharmaceuticals, Inc. in April 2011. Sagent Pharmaceuticals, Inc. was founded in 2006 and is headquartered in Schaumburg, Illinois.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Sagent Pharmaceuticals, Inc.

Corporate Governance 
Sagent Pharmaceuticals, Inc.’s ISS Governance QuickScore as of Oct 1, 2014 is 5. The pillar scores are Audit: 1; Board: 5; Shareholder Rights: 7; Compensation: 5.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Mr. Jeffrey M. Yordon , 65
Founder, Chairman and Chief Exec. Officer
1.25M0.00
Mr. James M. Hussey R.Ph., MBA, 55
Pres
531.00K0.00
Mr. Jonathon M. Singer , 50
Chief Financial Officer and Exec. VP
502.00K0.00
Mr. Michael Logerfo , 50
Chief Legal Officer, Exec. VP and Corp. Sec.
479.00K0.00
Mr. Albert Patterson R.Ph., 71
Exec. VP of National Accounts & Corp. Devel.
451.00K0.00
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders